Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

Elanco Animal Health Inc. diskutieren

Elanco Animal Health Inc.

WKN: A2N6BH / Symbol: ELAN / Name: Elanco Animal Health / Aktie / Pharmazeutika / Large Cap /

11,75 €
1,58 %

Buy Elanco Animal Health Inc.

Einschätzung Sell
Rendite (%) 4,39 %
Kursziel 8,67
Veränderung
Endet am 08.08.24

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $8.50 to $9.50. They now have a "sell" rating on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,51 %
Kursziel 16,68
Veränderung
Endet am 07.12.24

Elanco Animal Health Incorporated (NYSE: ELAN) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $18.00 price target on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,86 %
Kursziel 14,65
Veränderung
Endet am 15.12.24

Elanco Animal Health Incorporated (NYSE: ELAN) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $16.00 price target on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,17 %
Kursziel 15,50
Veränderung
Endet am 19.12.24

Elanco Animal Health Incorporated (NYSE: ELAN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Sell
Rendite (%) -13,57 %
Kursziel 11,52
Veränderung
Endet am 17.01.25

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $12.50. They now have a "sell" rating on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) -22,57 %
Kursziel 17,52
Veränderung
Endet am 27.02.25

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at Barclays PLC from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) -22,57 %
Kursziel 15,66
Veränderung
Endet am 27.02.25

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at Morgan Stanley from $16.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Sell
Rendite (%) -22,57 %
Kursziel 12,90
Veränderung
Endet am 27.02.25

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $12.50 to $14.00. They now have a "sell" rating on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,43 %
Kursziel 21,33
Veränderung
Endet am 09.05.25

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target raised by analysts at Barclays PLC from $19.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for ELAN provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,73 %
Kursziel 19,59
Veränderung
Endet am 28.06.25

Elanco Animal Health Incorporated (NYSE: ELAN) had its price target lowered by analysts at Barclays PLC from $23.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for ELAN provided by MarketBeat